As on 14-Aug-2024 10:28 IST
₹30.33
₹30.30
₹30.79
₹29.30
39,471
₹22.05 - 43.89
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Bharat Immuno
| -15.70 | 3.11 | -0.83 | 25.90 | -16.83 | 35.39 | -2.52 |
BSE Healthcare
| 29.84 | 6.68 | 16.72 | 46.55 | 16.54 | 26.64 | 12.71 |
BSE Small Cap
| 23.89 | -2.12 | 16.73 | 49.81 | 26.12 | 33.39 | 18.47 |
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
---|---|---|---|---|---|---|---|
Bharat Immuno
| -11.40 | -31.74 | 11.97 | 598.76 | -38.50 | -65.77 | 67.64 |
BSE Small Cap
| 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 | 59.64 |
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
No Review & Analysis are available.
The total asset value of Bharat Immunologicals & Biologicals Corporation Ltd stood at ₹ 189 Cr as on 31-Mar-23
The share price of Bharat Immunologicals & Biologicals Corporation Ltd is ₹29.80 (BSE) as of 14-Aug-2024 10:28 IST. Bharat Immunologicals & Biologicals Corporation Ltd has given a return of -16.83% in the last 3 years.
Bharat Immunologicals & Biologicals Corporation Ltd has a market capitalisation of ₹ 131 Cr as on 13-Aug-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Bharat Immunologicals & Biologicals Corporation Ltd is -4.03 times as on 13-Aug-2024, a 645% discount to its peers’ median range of 0.74 times.
Since, TTM earnings of Bharat Immunologicals & Biologicals Corporation Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Bharat Immunologicals & Biologicals Corporation Ltd and enter the required number of quantities and click on buy to purchase the shares of Bharat Immunologicals & Biologicals Corporation Ltd.
Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, ready to use therapeutic food, low calorie sweetener tablets, etc. The company was founded in 1989 and is based in Bulandshahr, India.
The promoter of Bharat Immunologicals & Biologicals Corporation Ltd is PRESIDENT OF INDIA. PRESIDENT OF INDIA owns 59.25 per cent of the total equity. The chairman of the company is Sudhanshu Vrati , and the managing director is Dhananjay Kumar Tiwary..
There is no promoter pledging in Bharat Immunologicals & Biologicals Corporation Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
3,027
|
|
452
|
|
289
|
|
58
|
Bharat Immunologicals & Biologicals Corporation Ltd. | Ratios |
---|---|
Return on equity(%)
|
0
|
Operating margin(%)
|
-36.47
|
Net Margin(%)
|
-36.43
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Bharat Immunologicals & Biologicals Corporation Ltd was ₹-17 Cr.
No Review & Analysis are available.
Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, ready to use therapeutic... food, low calorie sweetener tablets, etc. The company was founded in 1989 and is based in Bulandshahr, India. Read more